Owens & Minor (NYSE:OMI) announced its quarterly earnings data on Wednesday. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.01, Bloomberg Earnings reports. The firm had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.34 billion. Owens & Minor had a return on equity of 10.85% and a net margin of 0.83%. The business’s revenue for the quarter was up .9% on a year-over-year basis. During the same period in the prior year, the business earned $0.52 EPS.
Owens & Minor (OMI) traded up $0.27 on Thursday, hitting $15.60. The stock had a trading volume of 2,523,407 shares, compared to its average volume of 1,610,000. Owens & Minor has a 52 week low of $14.26 and a 52 week high of $36.73. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.77 and a quick ratio of 0.95. The stock has a market cap of $955.49, a P/E ratio of 12.38, a PEG ratio of 1.41 and a beta of 0.92.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 15th will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, March 14th. This is an increase from Owens & Minor’s previous quarterly dividend of $0.26. This represents a $1.04 dividend on an annualized basis and a dividend yield of 6.67%. Owens & Minor’s dividend payout ratio (DPR) is 81.75%.
Several equities research analysts recently issued reports on OMI shares. Zacks Investment Research downgraded Owens & Minor from a “hold” rating to a “strong sell” rating in a research note on Friday, December 22nd. ValuEngine downgraded Owens & Minor from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Leerink Swann reissued a “market perform” rating and issued a $23.00 price objective (down from $34.00) on shares of Owens & Minor in a research note on Thursday, November 2nd. JPMorgan Chase & Co. reissued an “underweight” rating and issued a $22.00 price objective on shares of Owens & Minor in a research note on Tuesday, December 19th. Finally, Credit Suisse Group reaffirmed an “underperform” rating and set a $17.00 price target (down from $31.00) on shares of Owens & Minor in a research note on Monday, November 20th. Five equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. The stock currently has a consensus rating of “Sell” and an average price target of $26.21.
COPYRIGHT VIOLATION NOTICE: “Owens & Minor (OMI) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/14/owens-minor-omi-announces-earnings-results.html.
Owens & Minor Company Profile
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.